Filing Details

Accession Number:
0001179110-21-005645
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 21:06:05
Reporting Period:
2021-05-18
Accepted Time:
2021-05-20 21:06:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651561 Tabula Rasa Healthcare Inc. TRHC Services-Business Services, Nec (7389) 465726437
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685833 H Calvin Knowlton 228 Strawbridge Drive
Suite 100
Moorestown NJ 08057
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-18 12,000 $40.95 841,360 No 4 S Direct
Common Stock Disposition 2021-05-19 10,210 $40.76 831,150 No 4 S Direct
Common Stock Disposition 2021-05-19 1,790 $41.20 829,360 No 4 S Direct
Common Stock Disposition 2021-05-20 10,000 $40.74 706,908 No 4 S Indirect Held by spouse.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Held by spouse.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect Held by trust for children.
Common Stock 20,000 Indirect Held by trust for children.
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.38 to $41.33, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) (4) and (6) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.10 to $41.09, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.12 to $41.30, inclusive.
  5. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Orsula Knowlton on May 12, 2021.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.34 to $41.33 inclusive.